Smell the coronavirus
Very interesting article about Israel’s NanoScent (see previously), which has developed a device so sensitive that it can detect viruses in the breath, such as SARS-Cov2. 50% of employees are female and it is another example of Christian Arabs, Muslims, and Israeli Jews working side by side.
Anti-viral nasal spray is a hit
Israel’s Enovid (see previously) is ramping up production of its SaNOtize anti-Covid Nasal spray to keep up with demand. It is to manufacture up to 250,000 units per month in the US alone. In August, Enovid struck a deal with India’s Glenmark to manufacture the spray for South-East Asia.
Best of Health
Israel’s Aidoc, (see previously) has been selected the “Best New Health Application” award of the University of California San Francisco (UCSF) Health Awards competition. Aidoc’s artificial intelligence (AI) solutions have revolutionized medical imaging.
Massive donation for autism research
The Canadian-Israeli Azrieli Foundation has given NIS 40 million ($13 million) to the National Autism Research Centre of Israel in BeerSheba (see previously). It is the largest ever donation for an autism infrastructure project in Israel.
Fast genetic data analysis
Israel’s Geneyx Genomex utilizes the world’s largest unified global knowledge base for interrogating genetic-based diseases and disorders. It provides fast analysis, interpretation, and reporting to help labs accelerate the development of targeted and personalized therapeutics.
Natural remedies for feminine ailments
Israel’s Algamed is using natural-based compounds made from algae plus its own innovative FemTech to treat sensitive feminine conditions. The algae excretes a gel that keeps it moist, and has numerous anti-bacterial, anti-inflammatory, antiviral, and anti-aging benefits.
Innovative eye treatment technology
Israel’s BioLight (see previously) is partnering with Tel Aviv’s Sourasky (Ichilov) Medical Center, to locate and develop innovative technologies in ophthalmology. Also, Biolight’s subsidiary Diagnostear has begun a clinical trial in India of its diagnosis of Dry Eye Disease.
Small molecules to treat ALS
Israel’s Neuromagen is developing a new class of small molecules to treat ALS (Amyotrophic Lateral Sclerosis - Lou Gehrig’s Disease), and other neurodegenerative diseases. The molecules activate the enzyme telomerase reverse transcriptase, which protects and rehabilitates neuronal cells.
Digitizing neurology
Israel’s NeuraLight uses video from smartphone or web camera, to catch neurological patterns and digital markers. Its computer vision and deep learning algorithms help accelerate development of therapies including Parkinson’s, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases.
Silencing tumor communications
Researchers at Israel’s Technion Institute have developed a breakthrough cancer treatment by injecting analgesic nanoparticles into the bloodstream. These anaesthetize the nerves inside the tumors, shutting down communications between them, thus inhibiting tumor growth and spread.